PipGCE mice express an EGFP/Cre-ERT2 fusion protein in acinar cells of the neonatal and adult submandibular gland. These mice may have applications in studies requiring conditional gene manipulation in the submandibular gland, as well as for acinar cell lineage fate mapping.
Catherine Ovitt, University of Rochester
Genetic Background | Generation |
---|---|
|
Allele Type | Gene Symbol | Gene Name |
---|---|---|
Targeted (Recombinase-expressing, Inducible) | Pip | prolactin induced protein |
The prolactin-induced protein encoded by the Pip gene is secreted by apocrine cells into exocrine fluids. Prolactin-induced protein binds actin and is a biomarker for breast cancer. These knock-in mice express the GCE cassette (an EGFP/creERT2 fusion gene) from the endogenous Pip locus. When PipGCE mice are bred with mice containing loxP-flanked sequence, tamoxifen-inducible, cre-mediated recombination will result in deletion of the floxed sequences. Tamoxifen administration in double mutant mice, carrying this transgene and a reporter, induces Cre recombination in acinar cells of the submandibular gland. Although Pip is expressed as early as E14 in proacinar cells, cre activity is not detected in E15.5 or E17.5 submandibular gland. Tamoxifen inducible cre recombinase activity is not detected in parotid, sublingual or lacrimal glands, kidney, lung, pancreas, prostate, or ovary tissues. The Donating Investigator has not made the strain homozygous, although homozygotes are predicted to be viable and fertile. EGFP expression is not detected by direct fluorescence or anti-GFP antibody (immunofluorescence). During backcrossing, the Y chromosome may not have been fixed to the C57BL/6J genetic background.
The Cre-ERT2 fusion protein consists of Cre recombinase fused to a triple mutant form of the human estrogen receptor, which does not bind its natural ligand (17β-estradiol) at physiological concentrations, but will bind the synthetic estrogen receptor ligands 4-hydroxytamoxifen (OHT or tamoxifen) and, with lesser sensitivity, ICI 182780. Restricted to the cytoplasm, Cre-ERT2 can only gain access to the nuclear compartment after exposure to tamoxifen. To counteract the mixed estrogen agonist effects of tamoxifen injections, which can result in late fetal abortions in pregnant mice, progesterone may be coadministered.
A targeting construct containing the GCE cassette (EGFP and cre/ERT2 fusion gene) followed by SV40 polyadenylation sequence and an FRT-flanked neo cassette was used to disrupt exon 1 of the targeted gene. The construct was electroporated into (129S6/SvEvTac x C57BL/6NCrl)F1-derived G4 embryonic stem (ES) cells. Correctly targeted ES cells were injected into C57BL/6J blastocysts, and chimeras were bred to C57BL/6J mice. The resulting Pip-GCE-Neo heterozygotes were then bred to Actin-Flippase mouse strain on a B6.129S4 genetic background (Stock No. 009086) to remove the FRT-flanked NEO cassette, generating PipGCE offspring. The mice were then backcrossed to C57BL/6 for 4 generations. During backcrossing, the Y chromosome may not have been fixed to the C57BL/6J genetic background.
Upon arrival, B6N4 sperm was cryopreserved. To establish our live colony, an aliquot of frozen sperm was used to fertilize C57BL/6J oocytes (Stock No. 000664).
Expressed Gene | cre/ERT2, Cre recombinase and estrogen receptor 1 (human) fusion gene, |
---|---|
Site of Expression | Tamoxifen administration results in cre expression from an EGFP/creERT2 fusion gene in acinar cells of the submandibular gland. |
Allele Name | targeted mutation 1.1, Catherine E Ovitt |
---|---|
Allele Type | Targeted (Recombinase-expressing, Inducible) |
Allele Synonym(s) | Pip GCE; Piptm2(GCE)Ovi; Pip-GFP-CreERT2 |
Gene Symbol and Name | Pip, prolactin induced protein |
Gene Synonym(s) | |
Expressed Gene | cre/ERT2, Cre recombinase and estrogen receptor 1 (human) fusion gene, |
Site of Expression | Tamoxifen administration results in cre expression from an EGFP/creERT2 fusion gene in acinar cells of the submandibular gland. |
Strain of Origin | (129S6/SvEvTac x C57BL/6NCrl)F1 |
Chromosome | 6 |
Molecular Note | The eGFP-CreERT2 (GCE) fragment with an SV40 poly adenylation site and neomycin resistance cassette were inserted immediately downstream of the translational initiation codon ATG. The knock-in construct removed the coding sequences from exon 1 and placed the GCE gene under the control of the endogenous regulatory sequences. Flp-mediated recombination removed the selection cassette. The EGFP could not be detected by direct fluorescence or anti-GFP antibody staining. |
When maintaining a live colony, heterozygous mice may be bred together, to wildtype siblings, or to C57BL/6J inbred mice (Stock No. 000664). The Donating Investigator has not made the strain homozygous.
When using the B6.Cg-Piptm1.1(cre/ERT2)Ovi/J mouse strain in a publication, please cite the originating article(s) and include JAX stock #023201 in your Materials and Methods section.
Facility Barrier Level Descriptions
Service/Product | Description | Price |
---|---|---|
Heterozygous or woldtype for Pip<tm1.1(cre/ERT2)Ovi> |
Frozen Mouse Embryo | B6.Cg-Pip<tm1.1(cre/ERT2)Ovi>/J | $2595.00 |
Frozen Mouse Embryo | B6.Cg-Pip<tm1.1(cre/ERT2)Ovi>/J | $2595.00 |
Frozen Mouse Embryo | B6.Cg-Pip<tm1.1(cre/ERT2)Ovi>/J | $3373.50 |
Frozen Mouse Embryo | B6.Cg-Pip<tm1.1(cre/ERT2)Ovi>/J | $3373.50 |
Terms are granted by individual review and stated on the customer invoice(s) and account statement. These transactions are payable in U.S. currency within the granted terms. Payment for services, products, shipping containers, and shipping costs that are rendered are expected within the payment terms indicated on the invoice or stated by contract. Invoices and account balances in arrears of stated terms may result in The Jackson Laboratory pursuing collection activities including but not limited to outside agencies and court filings.
The Jackson Laboratory has rigorous genetic quality control and mutant gene genotyping programs to ensure the genetic background of JAX® Mice strains as well as the genotypes of strains with identified molecular mutations. JAX® Mice strains are only made available to researchers after meeting our standards. However, the phenotype of each strain may not be fully characterized and/or captured in the strain data sheets. Therefore, we cannot guarantee a strain's phenotype will meet all expectations. To ensure that JAX® Mice will meet the needs of individual research projects or when requesting a strain that is new to your research, we suggest ordering and performing tests on a small number of mice to determine suitability for your particular project. We do not guarantee breeding performance and therefore suggest that investigators order more than one breeding pair to avoid delays in their research.
What information were you hoping to find through your search?
How easy was it to find what you were looking for?
We may wish to follow up with you. Enter your email if you are happy for us to connect and reachout to you with more questions.
Please Enter a Valid Email Address
Thank you for sharing your feedback! We are working on improving the JAX Mice search. Come back soon for exciting changes.